Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
Montauk Renewables (MNTK) Q3 Earnings Preview: What Investors Should Watch

Montauk Renewables (MNTK) Q3 Earnings Preview: What Investors Should Watch

Key Takeaways

  • Montauk Renewables is scheduled to report results for its third quarter ended September 30, 2026, after the market close on Monday, November 9, 2026.
  • Wall Street consensus expects earnings of $0.05 per share on revenue of $53.34 million, up from $0.04 per share and $45.26 million in the same quarter a year ago.
  • Management has committed to selling the majority of its expected third-quarter RINs (Renewable Identification Numbers) at an average of roughly $2.66, above the July 2026 D3 index price of $2.64.
  • Investors will focus on renewable natural gas (RNG) production volumes, RIN pricing, renewable electricity output, and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization).
  • The Turkey, North Carolina facility began generating power for sale in July 2026, so this report offers an early read on its ramp-up.
  • Full-year 2026 guidance remains a key benchmark: RNG revenue of $175–$190 million and renewable electricity revenue of $33–$37 million.

Why This Earnings Report Matters

This third-quarter report arrives at an important inflection point for MNTK. After a comparatively soft 2025, revenue growth has reaccelerated, with second-quarter 2026 revenue climbing 19.7% year over year. Because the company self-markets much of its environmental attributes, profitability swings meaningfully with RIN prices and with management's decisions on when to sell them. The Turkey, North Carolina facility began generating power in July 2026, making this the first report to capture early contributions from that ramp-up. With 2026 guidance reaffirmed, investors are watching for evidence that the company's improving trajectory is durable rather than driven by one-off factors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Earnings Expectations

Analysts expect MNTK to post third-quarter earnings of $0.05 per share on revenue of $53.34 million, according to consensus estimates. That would compare with $0.04 per share and $45.26 million in the prior-year period, implying expected revenue growth of roughly 18%.

Beyond the headline figures, investors will scrutinize operating metrics. RNG production is typically measured in MMBtu (million British thermal units), while renewable electricity output is measured in MWh (megawatt-hours). RIN pricing remains central: management has said it committed to selling the majority of expected third-quarter RINs at an average of about $2.66, above the July 2026 D3 index price of $2.64. Adjusted EBITDA will also be closely watched after it surged 144.5% year over year in the second quarter to $12.3 million.

Historically, MNTK shares have produced above-average swings around earnings, reflecting sensitivity to RIN prices, production volumes, and regulatory developments in the renewable fuels market.

Market Reaction and Investor Sentiment

Sentiment heading into this report is cautiously optimistic. Montauk's second-quarter results showed a clear return to top-line growth, and the company's disclosed RIN sale commitments suggest management locked in pricing above recent index levels—a potentially supportive signal for the quarter's environmental attribute revenue.

Still, the stock has historically moved sharply around earnings, and key risks remain. RIN prices and renewable fuel credit markets can be volatile, and regulatory developments—particularly around North Carolina's Clean Energy Portfolio Standard and swine RECs (Renewable Energy Certificates)—can shift demand. The pace of the Turkey facility's production ramp and any updates on project costs will also shape how investors interpret the quarter.

Forward Outlook and Key Factors to Monitor

The most important item after the release will be whether management reaffirms or adjusts its full-year 2026 guidance. The company has previously guided to RNG production of 5.8–6.0 million MMBtu, RNG revenue of $175–$190 million, and renewable electricity production of 195,000–207,000 MWh with revenue of $33–$37 million. Any change to these ranges would be a meaningful signal.

Investors should also track the Turkey, North Carolina ramp-up. Management has indicated it expects production volumes to increase through the second half of 2026 as additional feedstock collection comes online, with the first phase of the project carrying an unchanged capital investment expectation of roughly $200 million.

Finally, watch RIN pricing and sales strategy. Because Montauk self-markets a large share of its RINs, the timing and realized price of these sales can materially affect quarterly results. Regulatory outcomes and broader renewable fuels market conditions will continue to influence both revenue and sentiment in the quarters ahead. From what I see, this is important because it ties directly into the durability of the growth story.

Using AI Tools for Deeper Analysis

In preparing for earnings season, I often turn to Tickeron's AI Screener to quickly filter renewable energy names and compare technical and fundamental setups across the sector. It helps surface patterns and performance metrics that might otherwise take hours to review manually, giving a clearer sense of where MNTK stands relative to peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MNTK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MNTK in upward trend: price rose above 50-day moving average on November 02, 2026

MNTK moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on MNTK as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for MNTK just turned positive on November 02, 2026. Looking at past instances where MNTK's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.

Following a +10.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 154 of 176 cases where MNTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

MNTK broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. MNTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.431) is normal, around the industry mean (2.450). P/E Ratio (53.200) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).

The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.82B. The market cap for tickers in the group ranges from 50 to 241.89B. LIN holds the highest valuation in this group at 241.89B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -7%. SNES experienced the highest price growth at 25%, while YMAT experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 62%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ChemicalsSpecialty

Industry
N/A
Address
5313 Campbells Run Road
Phone
+1 412 747-8700
Employees
189
Web
https://ir.montaukrenewables.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 EPS (earnings per share) of $0.93, reflecting 2.2% year-over-year growth. Consensus revenue estimate stands at $1.47 billion, approximately flat compared to Q1 2025's $1.467 billion.
Analysts expect Q1 2026 revenue of around $224 million, a significant increase from $108 million in Q1 2025. Consensus EPS forecast points to a loss of approximately $2.29 per share, potentially improved from prior quarters.